BiomX receives NYSE American delisting notice for equity deficiency; interim CFO departs

BiomX Inc.

Stockholders' capital deficiency of $9.5M as of March 31, 2024; losses in five recent fiscal years.
Plan to regain compliance due June 22, 2024; final compliance deadline November 23, 2025.
Expects to reclassify $32.4M to equity via Series X Preferred conversion at July 2024 shareholder meeting.
Common stock to trade with '.BC' designation during cure period.
Interim CFO Avraham Gabay steps down May 31, 2024; CFO Marina Wolfson returns from maternity leave.

item 3.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Marina Wolfson

Chief Financial Officer

PHGE · BiomX Inc.

Effective: 2024-05-31
Filed: May 30, 2024, 7:59 PM ET

following Ms. Marina Wolfson’s return from maternity leave

Departed (interim)

Avraham Gabay

Interim Chief Financial Officer

PHGE · BiomX Inc.

Effective: 2024-05-31
Successor: Marina Wolfson
Filed: May 30, 2024, 7:59 PM ET

Effective May 31, 2024, Mr. Avraham Gabay’s term as Interim Chief Financial Officer of the Company will conclude

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.85

Marina Wolfson was appointed as Chief Financial Officer at BiomX Inc..

Action: returned
Role: Chief Financial Officer

Exact text from the filing

following Ms. Marina Wolfson’s return from maternity leave

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Avraham Gabay departed as Interim Chief Financial Officer at BiomX Inc..

Action: concluded
Role: Interim Chief Financial Officer

Exact text from the filing

Effective May 31, 2024, Mr. Avraham Gabay’s term as Interim Chief Financial Officer of the Company will conclude

View on SEC.gov

BiomX Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-048030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.